2017

1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

   New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

2. Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study

   Respiratory Medicine, Vol. 132, pp. 68-75